Literature DB >> 32959113

Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT.

A Gosewisch1, M Schleske1, F J Gildehaus1, I Berg1, L Kaiser1, J Brosch1, P Bartenstein1, A Todica1, H Ilhan2, G Böning1.   

Abstract

Entities:  

Year:  2020        PMID： 32959113     DOI： 10.1007/s00259-020-05024-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

Review 1.  Compton imaging for medical applications.

Authors:  Hideaki Tashima; Taiga Yamaya
Journal:  Radiol Phys Technol       Date:  2022-07-22

2.  PSMA theragnostics for metastatic castration resistant prostate cancer.

Authors:  Hong Song; Kip E Guja; Andrei Iagaru
Journal:  Transl Oncol       Date:  2022-05-31       Impact factor: 4.803

3.  Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.

Authors:  Nadia Benabdallah; William Scheve; Nicholas Dunn; Delynn Silvestros; Paul Schelker; Diane Abou; Uday Jammalamadaka; Richard Laforest; Zekun Li; Jonathan Liu; David H Ballard; Nichole M Maughan; Hiram Gay; Brian C Baumann; Robert F Hobbs; Buck Rogers; Amir Iravani; Abhinav K Jha; Farrokh Dehdashti; Daniel L J Thorek
Journal:  Theranostics       Date:  2021-09-27       Impact factor: 11.556

4.  Quantitative SPECT/CT imaging of lead-212: a phantom study.

Authors:  Monika Kvassheim; Mona-Elisabeth R Revheim; Caroline Stokke
Journal:  EJNMMI Phys       Date:  2022-08-04

Review 5.  Radionuclides for Targeted Therapy: Physical Properties.

Authors:  Caroline Stokke; Monika Kvassheim; Johan Blakkisrud
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

6.  Relative Efficacy of 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer Based on Subcellular Dosimetry.

Authors:  Hwan Lee
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02

Review 7.  Global experience with PSMA-based alpha therapy in prostate cancer.

Authors:  Mike M Sathekge; Frank Bruchertseifer; Mariza Vorster; Alfred Morgenstern; Ismaheel O Lawal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-26       Impact factor: 9.236
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.